Supira Medical

Supira Medical was founded in 2012 and is headquartered in California, USA. The company is dedicated to developing the next generation of percutaneous ventricular assist devices (pVADs), which can be used for high-risk patients undergoing interventional procedures.The low-profile, high-flow percutaneous ventricular assist device (pVAD) developed by Supira Medical is used during stent placement or angioplasty to provide temporary hemodynamic support for patients with severe coronary artery disease or comorbidities. The device can also be used to treat patients with cardiogenic shock (CS), improving outcomes for these high-risk patients.